Court of Customs and Patent Appeals April 23, 1970, Patent Appeal 8246 (Application of Theodor Petrzilka, Albert Hofmann, Hansruedi Schenk, Franz Troxler, Albert Frey and Hans Ott)

Also known as

United States · · · 23-04-1970

RICH, Acting Chief Judge.

This appeal is from the decision of the Patent Office Board of Appeals affirming the rejection of claim 5 of application serial No. 329,972, filed December 12, 1963, entitled “Therapeutically Active 10-Methoxy-Deserpidine,” a continuation-in-part of application serial No.

*1103

728,112, filed April 14, 1958. We reverse.

Claim 5, the only claim remaining in the application, reads:

Laevorotatory

1

10-methoxy-deserpidine. This single chemical compound (hereinafter “10-MD”), has the following structural formula:

This compound is a blood-pressure-reducing agent or “hypotensive” agent.

The appealed claim is rejected under 35 U.S.C. § 103 as unpatentable over either of the following United States patents:

Kuehne 2,857,385 Oct. 21,1958

(Filed Apr. 17,1956)

Woodward 2,883,384 Apr. 21,1959

(Filed May 3,1956)

These references are cited as disclosing “reserpine” (“11-methoxy-deserpidine”) and related compounds, processes for preparing the same, and processes for resolving mixtures of the laevorotatory and dextrorotatory isomers thereof. The

structure

of laevorotatory reserpine differs from that of appellants’ compound in only one seemingly minor respect: with reference to the structural formula of appellants’ compound, supra, laevorotatory reserpine has a methoxy or “H3CO-” group in the 11-position rather than the 10-position. The generic disclosures of Kuehne and Woodward are broad enough to emcompass appellants’ compound. The Patent Office, however, does not contend that appellants’ compound is disclosed in the sense of 35 U.S.C. § 102.

Appellants’ principal contentions are: (1) that the Patent Office has not made out even a prima facie case of obvious

*1104

ness; and (2) assuming that a prima facie case of obviousness has been made out, that appellants’ have shown that their compound possesses such unexpected properties in comparison to reserpine as to rebut obviousness under the statute.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.